<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01244178</url>
  </required_header>
  <id_info>
    <org_study_id>10-003-GEN</org_study_id>
    <nct_id>NCT01244178</nct_id>
  </id_info>
  <brief_title>Hyperinsulinemic Therapy in Sepsis</brief_title>
  <official_title>Hyperinsulinemic Therapy in Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>peter metrakos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insulin regulates blood sugar and acts to suppress inflammation. Hyperinsulinemic Therapy is
      a protocol for Insulin administration that involves the administration of a calculated higher
      dose of insulin into the blood stream. This therapy is called dextrose/insulin clamp. It has
      been shown to be safe and successful in maintaining normal glucose levels.

      The objective of the study is to assess if the clamp can achieve a steady and normal blood
      glucose level in patients admitted to the intensive care unit with sepsis. Furthermore, if
      the higher insulin dose would lead to a drop in the inflammatory response seen in septic
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose Control</measure>
    <time_frame>During ICU stay (average one week)</time_frame>
    <description>Measures glucose control using the hyperinsulinemic/normoglycemic clamp in patients with septic shock</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory cytokines and biochemical hormonal response</measure>
    <time_frame>At randomization then at 6,24, 120 hours</time_frame>
    <description>Measurement of specific cytokines and hormonal responses to hyperinsulinemic therapy in patients with septic shock</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Tight Glucose Control Hyperinsulinemic Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Tight Glucose Control Hyperinsulinemic Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Insulin Protocol Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <description>Intravenous Hyperinsulinemic therapy</description>
    <arm_group_label>Tight Glucose Control Hyperinsulinemic Group</arm_group_label>
    <arm_group_label>Non-Tight Glucose Control Hyperinsulinemic Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <description>Standard Intravenous Insulin Therapy</description>
    <arm_group_label>Standard Insulin Protocol Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission to the ICU with a diagnosis of Septic shock or Severe Sepsis.

        Exclusion Criteria:

          -  Age less than 18 years old.

          -  Pregnancy.

          -  Patients who cannot provide informed consent and there is no surrogate decision maker.

          -  A delay of more than 24 hours between eligibility and randomization.

          -  Patients admitted to the intensive care unit for treatment of diabetic ketoacidosis or
             hyperosmolar state.

          -  Imminent death.

          -  Patients who the treating clinicians are not committed to full supportive care. This
             is confirmed by a documented treatment-limitation order that exceeds a
             &quot;do-not-resuscitation&quot; order.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Metrakos, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Khalid Univesity Hospital</name>
      <address>
        <city>Riyadh</city>
        <zip>11421</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2010</study_first_submitted>
  <study_first_submitted_qc>November 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2010</study_first_posted>
  <last_update_submitted>October 24, 2013</last_update_submitted>
  <last_update_submitted_qc>October 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>peter metrakos</investigator_full_name>
    <investigator_title>Associate Professor of Surgery and Associate Professor in Anatomy and Cell Biology McGill University</investigator_title>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

